Next Article in Journal
Endothelin-1 Induces Cell Proliferation and Myofibroblast Differentiation through the ETAR/Gαq/ERK Signaling Pathway in Human Cardiac Fibroblasts
Previous Article in Journal
Intracellular Helix-Loop-Helix Domain Modulates Inactivation Kinetics of Mammalian TRPV5 and TRPV6 Channels
Previous Article in Special Issue
Magnetic Multi-Enzymatic System for Cladribine Manufacturing
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Biocatalysis: An Eco-Friendly Scenario for the Manufacturing of APIs

by
Jesús Fernández-Lucas
1,2
1
Applied Biotechnology Group, Biomedical Science School, Universidad Europea de Madrid, Urbanización El Bosque, Calle Tajo, s/n, 28670 Villaviciosa de Odón, Spain
2
Grupo de Investigación en Ciencias Naturales y Exactas, GICNEX, Universidad de la Costa, CUC, Calle 58 # 55–66, Barranquilla 080002, Colombia
Int. J. Mol. Sci. 2023, 24(5), 4474; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms24054474
Submission received: 28 December 2022 / Accepted: 22 February 2023 / Published: 24 February 2023
(This article belongs to the Special Issue Biocatalysis: An Eco-Friendly Scenario for the Manufacturing of APIs)
Nowadays, the worldwide demand for Active Pharmaceutical Ingredients (APIs) requires novel, cost-effective, safe, and environmentally friendly synthetic processes. Given this scenario, biocatalysis has started to take an ever-growing impact on industrial chemical processes [1,2]. The application of enzymes to catalyze industrial reactions has the potential to make chemical processes less contaminant and more sustainable, in accordance with the concept and principles of Green Chemistry [3]. Moreover, biocatalysis offers additional advantages, such as the possibility to perform one-pot reactions, a higher region- and stereo-selectivity, or the absence of intermediates that require tedious purification steps, which make enzyme-mediated processes a powerful ally for a successful industrial implementation of a process.
Gone are the days when the harsh operational conditions, the narrow specificity and low promiscuity of enzymes, or the high cost of enzyme production usually hampered the industrial applications of enzymes for APIs manufacturing. In contrast, recent advances in biocatalysis lead to a breeding ground to satisfy industry requirements [4].
This Special Issue will cover some recent and relevant findings concerning the enzyme-mediated manufacturing of APIs. To this end, a total of seven articles, including five experimental articles and two revisions, were compiled to show the state of the art.
Due to the harsh conditions commonly used in industry, biocatalyst stabilization is an essential attribute for industrial implementation. In this respect, different experimental articles address this topic. In the first article, Mao and coworkers [5] evaluate the characteristics of different polymers as crosslinking agents to improve the stability and catalytic properties of Thermomyces lanuginosus lipase adsorbed onto hydrophobic supports. In a similar vein, Di Fabio et al. [6] display a novel biocatalyst for the oxidative deamination of a wide range of primary amines into the corresponding aldehydes based on the covalent immobilization of amino oxidase from Lathyrus cicero onto magnetic microparticles.
The transglycosylation reaction catalyzed by nucleoside phosphorylases (NPs) [7] or 2’-deoxyribosyltransferases (NDTs) [2] has proven to be a versatile tool for the synthesis of a wide spectrum of nucleoside analogs. To this end, an engineered NDT from Lactobacillus delbrueckii has been designed by Cruz et al. [8] by prediction of disulfide bond engineering sites. Additionally, this new thermostable variant was successfully employed as a catalyst for the enzyme-mediated production of nelarabine. Similarly, Drenichev et al. [9] performed a comparative analysis of the transglycosylation conditions catalyzed by different E. coli NPs. As a consequence, different ribonucleoside analogs were synthesized at different experimental conditions through a two-step reaction catalyzed by different purine and pyrimidine NPs. In another contribution, Cruz et al. [10] explored the viability of a magnetic multi-enzymatic system for cladribine production, based on the sequential action of Leismanhia mexicana type I NDT (LmPDT) and hypoxanthine phosphoribosyltransferase from E. coli (EcHGPRT) immobilized onto magnetic microspheres.
Following this tendency, Siedentop and Rosenthal [11] present an exhaustive revision of the industrial implementation of enzymatic cascades for API manufacturing. Moreover, the authors pay special attention to multi-enzymatic reactions for API synthesis that are close to an industrial application, including economic and ecological to assess their environmental friendliness and applicability.
Last but not least, Godoy et al. highlight the importance of biocatalyst design and process engineering to assess the potential of microbial lipases as biocatalysts for the production of pharmaceutical building blocks [12]. The authors focused their work on the comprehension of the structure–function relationship of microbial lipases but also included detailed comments about recent trends in the immobilization of lipases. Finally, a comprehensive description of microbial lipase application development toward a greener industry was presented.
We hope that the advances presented in this Special Issue will be of interest to the readers. We thank all the authors, reviewers, and Editorial Board members of International Journal of Molecular Sciences, whose contributions and support were vital to the publication of this Special Issue.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Woodley, J.M. New opportunities for biocatalysis: Making pharmaceutical processes greener. Trends Biotechnol. 2008, 26, 321–327. [Google Scholar] [CrossRef] [PubMed]
  2. Del Arco, J.; Acosta, J.; Fernández-Lucas, J. New trends in the biocatalytic production of nucleosidic active pharmaceutical ingredients using 2′-deoxyribosyltransferases. Biotechnol. Adv. 2021, 51, 107701. [Google Scholar] [CrossRef] [PubMed]
  3. Schaub, T. Efficient industrial organic synthesis and the principles of green chemistry. Chem. Eur. J. 2021, 27, 1865–1869. [Google Scholar] [CrossRef] [PubMed]
  4. Woodley, J.M. Accelerating the implementation of biocatalysis in industry. Appl. Microbiol. Biotechnol. 2019, 103, 4733–4739. [Google Scholar] [CrossRef] [PubMed]
  5. Mao, Y.; Cai, Z.; Zhou, C.; Lan, H.; Ye, X. Characteristics of crosslinking polymers play major roles in improving the stability and catalytic properties of immobilized Thermomyces lanuginosus lipase. Int. J. Mol. Sci. 2022, 23, 2917. [Google Scholar] [CrossRef] [PubMed]
  6. Di Fabio, E.; Iazzetti, A.; Incocciati, A.; Caseli, V.; Fabrizi, G.; Boffi, A.; Bonamore, A.; Macone, A. Immobilization of Lathyrus cicera amine oxidase on magnetic microparticles for biocatalytic applications. Int. J. Mol. Sci. 2022, 23, 6529. [Google Scholar] [CrossRef] [PubMed]
  7. Lapponi, M.J.; Rivero, C.W.; Zinni, M.A.; Britos, C.N.; Trelles, J.A. New developments in nucleoside analogues biosynthesis: A review. J. Mol. Catal. B Enzym. 2016, 133, 218–233. [Google Scholar] [CrossRef]
  8. Cruz, G.; Acosta, J.; Mancheño, J.M.; Del Arco, J.; Fernández-Lucas, J. Rational design of a thermostable 2′-deoxyribosyltransferase for nelarabine production by prediction of disulfide bond engineering sites. Int. J. Mol. Sci. 2022, 23, 11806. [Google Scholar] [CrossRef] [PubMed]
  9. Drenichev, M.S.; Oslovsky, V.E.; Zenchenko, A.A.; Danilova, C.V.; Varga, M.A.; Esipov, R.S.; Lykoshin, D.D.; Alexeev, C.S. Comparative analysis of enzymatic transglycosylation using E. coli nucleoside phosphorylases: A synthetic concept for the preparation of purine modified 2′-deoxyribonucleosides from ribonucleosides. Int. J. Mol. Sci. 2022, 23, 2795. [Google Scholar] [CrossRef] [PubMed]
  10. Cruz, G.; Saiz, L.P.; Bilal, M.; Eltoukhy, L.; Loderer, C.; Fernández-Lucas, J. Magnetic multi-enzymatic system for cladribine manufacturing. Int. J. Mol. Sci. 2022, 23, 13634. [Google Scholar] [CrossRef] [PubMed]
  11. Siedentop, R.; Rosenthal, K. Industrially relevant enzyme cascades for drug synthesis and their ecological assessment. Int. J. Mol. Sci. 2022, 23, 3605. [Google Scholar] [CrossRef] [PubMed]
  12. Godoy, C.A.; Pardo-Tamayo, J.S.; Barbosa, O. Microbial lipases and their potential in the production of pharmaceutical building blocks. Int. J. Mol. Sci. 2022, 23, 9933. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Fernández-Lucas, J. Biocatalysis: An Eco-Friendly Scenario for the Manufacturing of APIs. Int. J. Mol. Sci. 2023, 24, 4474. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms24054474

AMA Style

Fernández-Lucas J. Biocatalysis: An Eco-Friendly Scenario for the Manufacturing of APIs. International Journal of Molecular Sciences. 2023; 24(5):4474. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms24054474

Chicago/Turabian Style

Fernández-Lucas, Jesús. 2023. "Biocatalysis: An Eco-Friendly Scenario for the Manufacturing of APIs" International Journal of Molecular Sciences 24, no. 5: 4474. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms24054474

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop